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Background: Autosomal recessive primary microcephaly (MCPH) is a rare neurodevelopmental disease with severe
microcephaly at birth due to a pronounced reduction in brain volume and intellectual disability. Biallelic mutations
in the WD repeat-containing protein 62 gene WDR62 are the genetic cause of MCPH2. However, the exact
underlying pathomechanism of MCPH2 remains to be clarified.
Methods/results: We characterized the clinical, radiological, and cellular features that add to the human MCPH2
phenotype. Exome sequencing followed by Sanger sequencing in a German family with two affected daughters
with primary microcephaly revealed in the index patient the compound heterozygous mutations c.1313G>A
(p.R438H) / c.2864-2867delACAG (p.D955Afs*112) of WDR62, the second of which is novel. Radiological examination
displayed small frontal lobes, corpus callosum hypoplasia, simplified hippocampal gyration, and cerebellar
hypoplasia. We investigated the cellular phenotype in patient-derived lymphoblastoid cells and compared it with
that of healthy female controls. WDR62 expression in the patient’s immortalized lymphocytes was deranged, and
mitotic spindle defects as well as abnormal centrosomal protein localization were apparent.
Conclusion: We propose that a disruption of centrosome integrity and/or spindle organization may play an
important role in the development of microcephaly in MCPH2.
Keywords: Microcephaly, WDR62 mutation, Cell division, Intellectual disabilityIntroduction
Autosomal recessive primary microcephaly (MCPH) is a
rare neurodevelopmental disorder that results in severe
microcephaly at birth with reduction in brain volume,
simplified neocortical gyration, and intellectual disability
[1-3]. Biallelic mutations in the WD repeat-containing
protein 62 gene WDR62 cause MCPH2 (MIM#604317),
the second most common MCPH subtype [4]. So far,
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reproduction in any medium, provided the orin 27 families or individual patients worldwide, most of
them predicted to produce truncated proteins [4-12]
(Figure 1, Table 1). Despite the classic MCPH definition
of an isolated microcephaly at birth without severe archi-
tectonical abnormalities of the brain, patients with WDR62
mut.ations can display a wide spectrum of cortical mal-
formations including cortical thickening, polymicrogyria,
simplified gyral pattern, pachygyria, schizencephaly, hetero-
topias, and corpus callosum abnormalities. Some patients
also have evidence of lissencephaly, cerebellar hypoplasia,
and hippocampal dysmorphy [4,7,12] (Table 1).
WDR62 is essential for mitotic spindle stabilization
during mitosis and, as demonstrated in HeLa cells,
it accumulates at the centrosome or the nucleus in a
cell-cycle-dependent manner (from late prophase untiltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Phenotype and genotype of index patient. (A) Pedigree. (B) Facial phenotype of the patient. Note the sloping forehead, the convex
facial profile, the full lips, and the small chin. The appearance of low-set and posteriorly rotated ears on the lateral picture is partly due to reclination of
the head. See Additional file 1: Figure S1 for photo of sibling II:1. (C) Representative electropherogram traces confirm the heterozygous frameshift mutation
c.2864-2867delACAG in the index patient and her father and the heterozygous missense mutation c.1313G>A in the index patient and her mother
(NM_001083961.1 transcript reference sequence). (D) Sequence alignment of corresponding WDR62 protein regions depict the highly conserved amino
acids affected by the maternally inherited missense mutation (p.R438H) and the position of the paternally inherited frameshift mutation (p.D955Afs*112):
Human (Homo sapiens) UniProt O43379, Chimpanzee (Pan troglodytes) GenBank JAA38944.1, Rhesus monkey (Macaca mulatta) GenBank AFH29290.1,
Cat (Felis catus) GenBank XP_003998018.1, Mouse (Mus musculus) GenBank NP_666298.3, Fruit fly (Drosophila melanogaster) Fly Base ID FBgn0031374.
(E) Known WDR62 gene mutations according to HGMD Professional 2012.4 and the present paper. Mutations types are color-coded, i.e. missense in red,
frameshift in blue, nonsense in black, and splice site mutations in green. The positions of the mutations detected in the index patient are emphasized
through bold letters (c.1313G>A also present in the index patient has been previously reported [4]).
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proliferating precursors of the neuroepithelium in the
developing murine brain [4,7] but at the same time it is also
present in the cortical plate, a region where (postmitotic)
neurons reside [12]. WDR62 knockdown in cortical pro-
genitors by siRNA reduced their proliferative capacity,caused spindle orientation defects, decreased the integrity
of centrosomes and displaced them from spindle poles,
and delayed mitotic progression [13]. Despite considerable
interest in MCPH as a model disorder for isolated and con-
genital microcephaly, the exact underlying pathomechan-
ism remains to be established. Here, we report compound
Table 1 MCPH2 phenotypes and genotypes
Exon/Intron Mutation Alteration Ethnicity No. of
patients
Mc* at
birth
Mc* at
follow up
Neurological phenotype
Intellectual
disability
Speech
delay
Motor
delay
Epilepsy Spasticity Behavioral
abnormalities§
Ex2 c.193G>A p.V65M Arab 7 yes −5.3 to −9.8 SD + a,b + + - + -
Ex3 c.332G>C p.R111T Pakistani 6# −7 to −11 SD + - + - -
Ex4 c.363delT p.D112fs Mexican 3# −5 SD 10 m: -5.4 SD + + + - -
Ex5 c.535_536insA p.M179fs Indian 2# −4 to −9 SD + a,c + + + - -
Ex6 c.671G>C p.W224S 3# 2y: -3.5 SD + c - + + - +
Ex8 c.900C>A p.C300* Indian 2# −8 to −9 SD + a + + + - -
In8 c.1043 + 1G>A p.S348fs Turkish 1 −2.6 SD 2 m: -4.0SD - - - - -
5 m: -5.3SD
Ex9 c.1143delA p.H381fs Pakistani 2# −6 to −7 SD + + + - -
Ex9 c.1194G>A p.W398* Pakistani 4# −6 to −8 SD
Ex9 c.1198G>A p.E400K Hispanic 2# 9 m: -4 SD + + + - +
Ex10 c.1313G>A p.R438H Pakistani 6 yes −5 to −14 SD + a,b + - - - -
Ex10/23 c.1313G>A / c.2864-2867delACAG p.R438H / p.D955fs German 1 - 2.3 SD + a + + + - -
Ex11 c.1408C>T p.Q470* 1 yes + c - - + - -
Ex11 c.1531G>A p.D511N Pakistani 5 yes + a,b + - - - -
Ex12 c.1576G>T p.E526* 1 9 m: -4 SD + b - + + - -
Ex12 c.1576G>A p.E526K 1 3.5 y: -4 SD + c + - - - -
Ex15 c.1942C>T p.Q648* Pakistani 2# yes + - - - - -
Ex17/23 c.2083delA/c.2472_2473delAG p.S696fs / p.Q918fs 2# yes 8 y: -5 SD + + + + + -
In23 c.2867 + 4_c2867 + 7delGGTG p.S956fs Turkish 1 1 y: -8.5SD - + - - -
Ex27 c.3232G>A p.A1078T Pakistani 5 yes + a,b + - - - -
Ex28 c.3361delG p.A1121fs Pakistani 2# −10 to −11 SD
Ex29 c.3503G>A p.W1168* Pakistani 3# −9 to −11 SD - - + - +
Ex30 c.3839_3855del p.G1280fs Turkish 1 3 m: - 3.5SD + + + - -
Ex30 c.3936dupC p.V1314fs Caucasian 5 −2.8 SD −4 to −5 SD + + - - -
Turkish
Pakistani
Ex31 c.4205_4208delTGCC p.V1402fs Turkish 2# −5 to - 6 SD + c + + - - -
Ex31 c.4241dupT p.L1414fs Pakistani 9 yes + a,b + - - -
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Exon/Intron Neuroradiological phenotype Further phenotypes Reference
Simplified
gyration
Cortical
thickening
Corpus callosum
abnormalities
Pachygyria Polymicrogyria Schizencephaly Heterotopia
Ex2 + - + - + + - disproportionate sized face and ears
compared to the skull
[4,12]
Ex3 [11]
Ex4 + - + - - - - [12]
Ex5 - + - + - - - low set and prominent ears [6]
Ex6 - + + + - - - micrognathia [7]
Ex8 - - - + + - + [6]
In8 - - + - - - + [12]
Ex9 - - + - - + - [9]
Ex9 [11]
Ex9 - - - + - - - [5]
Ex10 + - - - - - - disproportionate sized face and ears
compared to the skull
[4,8]
Ex10/23 + - + - - - - bilateral pes planus and hallux valgus this study
Ex11 - + + + - - - genu varum, cryptorchidism, arachnodactly [7]
Ex11 disproportionate sized face and ears
compared to the skull
[4,8]
Ex12 - + + + - - - [7]
Ex12 - + + + - - - prognathism [7]
Ex15 + - - - - - - [8]
Ex17/23 - - - - + - - [10]
In23 - - + - - + [12]
Ex27 disproportionate sized face and ears
compared to the skull
[4]
Ex28 [11]
Ex29 [11]
Ex30 - - + - - - - [12]
Ex30 + + + - + - - broad nasal bridge, widely set eyes [4,8,12]
Ex31 - + + + - - - micrognathia, bulbous nose [7]
Ex31 disproportionate sized face and ears
compared to the skull
[4]
# Patients belong to one family.
* OFC in SDS, age in years (y) or months (m).
§ Behavioral abnormalities reported were hyperactivity and aggression.
a Mild, b Moderate, c Severe.
Table 1 MCPH2 phenotypes and genotypes (Continued)
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gene in a female MCPH2 patient of German descent and
describe her clinical and cellular phenotype. We thereby
provide evidence that the MCPH2 phenotype, at least
partly, is due to centrosome/spindle organization defects.
Human subjects and methods
Patients
Informed consent was obtained from the parents of the
index patient for the publication of clinical and radio-
logical data, cytogenetic and molecular genetic analyses,
and lymphoblastoid cell line (LCL) studies. DNA was
extracted from EDTA blood samples using standard
techniques [14]. Approval to conduct the present study
was obtained from the local ethics committee of the
Charité (approval no. EA1/212/08). The index patient is a
24-year-old microcephalic patient of German descent with
typical facial features of MCPH including sloping forehead
and severe intellectual delay. She also had astatic seizures,
which could be controlled by antiepileptic treatment.
Cranial imaging studies revealed small frontal lobes, hy-
poplasia of the corpus callosum, simplified hippocampal
gyration, widened lateral sulci, and cerebellar hypoplasia
with an enlarged cisterna magna. Her blood count was
normal, and there was no evidence of any malignant
disease. The detailed phenotype is delineated below.
Karyogram and array-CGH analysis
Standard karyotyping revealed a normal result (46,XX).
Array-CGH was performed on the NimbleGen Whole
Genome Tiling 135 k CGX-12 platform and revealed a
1.66 Mb duplication of the short arm of chromosome
2, arr[hg19] 2p12(82,018,317-83,674,828) × 3, that was
inherited from the healthy mother and comprised a
pseudogene (LOC1720) only.
Exome sequencing
All three family members (parents, index patient) were
subjected to exome sequencing. Genomic DNA was
isolated from blood samples using standard methods.
Five micrograms of genomic DNA were enriched using
the Agilent Human All Exon V3 kit (Agilent Technologies,
Santa Clara, CA, USA) following the manufacturer’s proto-
col. Whole-exome libraries were sequenced on an Illumina
HiSeq 2000 system for 1 × 101 cycles following the manu-
facturer’s instructions (Illumina, San Diego, CA, USA). All
raw sequencing reads were mapped onto UCSC hg19 [15]
using Burrows-Wheeler Aligner (BWA) 0.5.9-r169 [16] and
converted to BAM file format using SAMtools 0.1.18 [17].
Initial mappings were post-processed using the Genome
Analysis Toolkit (GATK) 1.6 [18] following their ‘best
practices V3′ (http://www.broadinstitute.org/gatk/guide/
best-practices). In brief, reads were realigned around sites
of known insertion-deletion polymorphisms (INDELs).Then, likely polymerase chain reaction PCR duplicates
were detected using Picard 1.48 [17]. Finally, raw base
quality scores were empirically recalibrated. Single nu-
cleotide polymorphisms (SNPs) and INDELs were identi-
fied using the UnifiedGenotyper from GATK. Variants
were classified as novel or known variants according to the
SNP database (dbSNP) 135 [19]. Functional conse-
quences of each variant were annotated using snpEff
2.0.5d20 [20] for UCSC hg19 RefSeq genes and
ENSEMBL 65 human gene models [15,21]. The potential
deleterious effect was evaluated using Polymorphism Phe-
notyping v2 (PolyPhen 2, [22]), sorting intolerant from
tolerant (SIFT, [23]), PhyloP [24], MutationTaster [25],
Genomic Evolutionary Rate Profiling (GERP++, [26]),
Likelihood Ratio Test (LRT, [27]), and the OMIM data-
base (http://www.ncbi.nlm.nih.gov/omim/), if available. Var-
iants were filtered for the two most likely inheritance
patterns, autosomal-dominant and autosomal-recessive
(either compound heterozygous or homozygous).
Sanger sequencing
The compound heterozygous mutations identified through
exome sequencing were verified through Sanger sequencing
using the primers: F1 5′-gtca tagtgctgtcattgagtcatc-3′, R1 5′
gagccaactggcaaagaatc-3′, F2 5′-gtgccacacctcttcctcatc-3′,
and R2 5′-cacctggaaccagggaacta-3′. The reference sequence
NM_001083961 ofWDR62 was used.
Establishment of Ebstein-Barr virus-transformed
lymphocytes and culture
Ebstein-Barr virus-transformed lymphocytes (LCLs) were
established according to the protocol published by H.
Neitzel 1986 [28]. LCLs were cultured in RPMI 1640
with L-Glutamine (Invitrogen, Darmstadt, Germany)
supplemented with 20% v/v fetal bovine serum (Invitrogen)
and 1% v/v penicillin-streptomycin (Sigma-Aldrich,
Taufkirchen, Germany) [29]. For this study, we used LCLs
from the patient and from two controls.
Immunocytology
For fixation, cells were cultured on poly-L-lysine
(Sigma-Aldrich) coated coverslips for 30 min at standard
conditions and subsequently incubated in paraformalde-
hyde (PFA) 4% for 10 min. Coverslips were rinsed with
phosphate buffered saline (PBS 1x) and further incubated
at room temperature in staining buffer (0.2% gelatin, 0.25%
Triton X-100 in PBS 1x) for 20 min. Blocking was achieved
by incubation in 10% donkey normal serum (DNS) in
staining buffer for 30 min. Coverslips were incubated
overnight at 4°C with primary antibodies in the staining
buffer containing 10% DNS followed by an incubation with
the corresponding secondary antibodies for 2 h at RT.
Nuclei were labeled with 4′,6-diamidino-2-phenylindole
(DAPI, 1:1,000, Sigma-Aldrich). Fluorescently labeled
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BX51 microscope with the software Magnafire 2.1B
(version 2001; Olympus, Hamburg, Germany), and all
images were processed using Adobe Photoshop. This
procedure has been previously described [29].
The anti-WDR62 antibody (rabbit polyclonal anti-
WDR62, Bethyl laboratories, A301-560A, 1:500) utilized
in this study recognizes amino acids between residue
900 and 950 of human WD repeat domain 62 (accession
no. NP_775907.4, GeneID 284403, UniProt ID: O43379).
Further primary antibodies were as follows: mouse anti-γ-
tubulin (T6557, Sigma-Aldrich, 1:500), mouse anti-α-tubulin
(T9026, Sigma-Aldrich; 1:1,500), and rabbit anti-CDK5RAP2
(HPA035820, Sigma-Aldrich, 1:200). The immunoreaction
specificity was analyzed in control specimen incubated only
in the secondary antibodies.Protein extraction procedure and Western blot
Protein extracts for Western blots were isolated from
LCLs by homogenization in radio-immunoprecipitation
assay (RIPA) buffer containing 1 mM phenylmethylsulfonyl
fluoride (PMSF; Sigma-Aldrich) and 1 protease inhibitor
cocktail tablet per 10 ml RIPA buffer (Complete Mini;
Roche Diagnostics, Mannheim, Germany), 15 min in-
cubation on ice, followed by ultrasonication and cen-
trifugation at 4°C for 10 min at 3,000 g and for 20 min
at 16,000 g. Protein concentrations were determined
using a bicinchoninic acid (BCA) based assay, according
to the instructions of the manufacturer (BCA Protein
Assay Kit; Pierce Biotechnology, Rockford, IL, USA).
Protein extracts (30 μg per sample) were denaturated
in Laemmli sample loading buffer at 95°C for 5 min,
separated by sodium dodecyl sulphate polyacrylamide
gel electrophoresis (SDS-PAGE), and electrophoretically
transferred onto nitrocellulose membrane (Bio-Rad,
Munich, Germany) using Bio-Rad wet transfer system
(Bio-Rad, Munich, Germany). This procedure has been
previously described [29].
The membranes were incubated for 1 h at room
temperature in blocking buffer Tris-Buffered Saline
Tween-20 (TBS-T) 1× with 5% bovine serum albumin
(BSA), rinsed three times with TBS-T (1×) for 8 min
each at RT on a shaker, and then incubated overnight
at 4°C with rabbit anti-WDR62 (1:500, A301-560A,
Bethyl laboratories) or mouse anti-actin (1:10,000,
MAB1501, Millipore) antibodies in blocking solution.
After incubation with the corresponding secondary
antibodies donkey anti-rabbit (1:2,000; Amersham
Biosciences, Freiburg, Germany) and goat anti-mouse
(1:10,000; Dako, Hamburg, Germany) the immunoreac-
tive proteins were visualized using a technique based on
a chemiluminescent reaction. The gel pictures were ob-
tained using photographic films (Amersham HyperfilmECL, GE Healthcare, UK). Western blot experiments were
run in triplicate.
Cell cycle analysis
Cell cycle analysis was performed using the 5-bromo-2′-
deoxyuridine (BrdU)-Hoechst 33258 method [30]. The
principle of that assay is based on the incorporation of
the halogenated base analog during DNA replication.
The assay makes use of the fact that BrdU-substituted
chromatin quenches the fluorescence of the dye Hoechst
33258. This method differentiates not only between cycling
and noncycling cells in a given culture but also recognizes
the distribution of the cycling cells in as many as four
consecutive cycles. For flow cytometry mononuclear
cells were Ficoll-isolated from heparinized blood sam-
ples. Cultures were set up in RPMI 1640 medium with
GlutaMAX (Gibco Life Technologies), supplemented
with 15% fetal bovine serum (FBS, PAN Biotech). Duplicate
cultures were either left untreated, or irradiated with
1.5 Gy from a linear accelerator or continuously exposed
to 10 ng/ml mitomycin C (Medac). To all of the cultures
BrdU (Sigma-Aldrich) was added at a final concentration
of 10-4 M [31]. Lymphocyte growth activation was induced
by phytohaemagglutinin (PHA HA16, Remel Europe,
Dartford, UK). The cells were harvested after 72 h. Following
staining with Hoechst 33258 (1.2 μg/ml; Molecular Probes)
for a minimum of 15 min in buffer containing 154 mM
sodium chloride (NaCl), 0.1 M TRIS pH 7.4, 1 mM calcium
chloride (CaCl2), 0.5 mM magnesium chloride (MgCl2),
0.2% BSA, and 0.1% nonyl phenoxypolyethoxylethanol
(NP40) in distilled water in the dark, ethidium bromide
(EB, 1.5 μg/ml, Molecular Probes) was added for another
minimum of 15 min. Bivariate flow histograms were
recorded on a triple-laser equipped LSRII flow cytometer
(Becton Dickinson) using UV excitation of Hoechst
33258 and 488-nm excitation of EB. The resulting cell
cycle distributions reflecting cellular DNA content
were quantified using the MPLUS AV software package
(Phoenix Flow Systems, San Diego, CA, USA).
Analysis of chromosome condensation
Whole-blood cultures were prepared using RPMI 1640
medium with GlutaMAX (Gibco Life Technologies) supple-
mented with 15% fetal bovine serum (FBS, PAN Biotech).
Lymphocytes were stimulated with PHA (Remel Europe).
The cultures were terminated after 72 h following addition
of 8 μl/ml Colcemid solution (10 μg/ml; PAA) for the final
45 min. Metaphase preparations were made by hypotonic in-
cubation of the cell pellets (0.075 M KCl for 10 min at 37°C)
and fixation of the nuclei in ice-cold methanol/concentrated
acetic acid 3:1. Slides were stained with 5% Giemsa so-
lution for 5 min without applying banding techniques.
A total 1,000 nuclei per sample were scored by visual
counts, and the proportion of metaphases and of nuclei
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defined as nucleus-shaped structures with condensed
chromosomes) were determined.
Results
Phenotype of the patient with MCPH2
The index patient is the third child of non-consanguineous
healthy parents of German descent (Figure 1A). Microceph-
aly was diagnosed by ultrasound in the 30th week of gesta-
tion. Pregnancy and delivery were uneventful. Birth
weight, length, and head circumference at term were 3600 g
(0.6 SDS, 50-75th centile), 55 cm (1.6 SDS, 95th centile),
and 31 cm (−2.3 SDS; 1 cm below 3rd centile), respectively.
The head circumference of her parents was normal. Post-
natal cranial ultrasound revealed small frontal lobes,
hypoplasia of the corpus callosum, simplified hippocampal
gyration, widened lateral sulci, and cerebellar hypoplasia
with an enlarged cisterna magna. Further imaging studies
were refused by the parents. These findings are in line with
cortical malformations previously associated with WDR62
mutations, and are expected to have impact on cognitive,
language, motor, and behavioral functions of the patient.
Language development of the girl was severely delayed
(first words at the age of 4 years) while the delay in motor
development (unaided walking at the age of 2 years) was
moderate [32]. At the age of 16 years, the patient developed
astatic seizures that were controlled by carbamazepine treat-
ment. At the age of 24 years, the patient was distinctively
microcephalic (50 cm, 3 cm below 3rd centile, -3.3 SDS)
while her body length of 164 cm (25th-50th centile) and
weight of 54 kg (25th-50th centile) were normal. She could
phrase sentences of up to three to four words and recog-
nized letters but was not able to perform any abstract intel-
lectual task such as reading, writing or simple calculation.
She also had difficulties in performing complex motor tasks
such as riding a bicycle. Neurological examination did not
reveal any further abnormality. Spatial orientation, vision
and hearing were normal. Facial features included convex
facial profile, sloping forehead, marginally low-set and
posteriorly rotated ears, small chin, and full lips. In spite
of the small cranium, palpebral fissures were horizontal.
On physical examination bilateral pes planus and hallux
valgus were found. Blood count was normal, and there
was no evidence of any malignancy or further organ
malformation/malfunction (Table 1). Results of genetic
analyses (karyogram and array-CGH) were normal.
The patient’s sister who was born earlier also had micro-
cephaly and intellectual disability (Additional file 1: Figure
S1). She died of a Wilms tumor at the age of 5 years (head
circumference at birth 31 cm, -2.3 SDS, 1 cm below 3rd
centile; head circumference at 2 years-of-age 41 cm, -4.4
SDS, 5 cm below 3rd centile). A left-sided spastic hemipar-
esis had been noticed. Brain computed tomography at one
month of age had revealed a plump right ventricle, widearachnoidal spaces, and parieto-occipital hypodensity. In
the second year of life, an electroencephalogram (EEG) had
revealed signal depression on the right hemisphere and epi-
leptic activity on the left hemisphere. Results of genetic
analyses (Karyogram and array-CGH) had been normal.
Novel WDR62 mutation
Both parents and the index patient were subjected to whole
exome sequencing. In total, we obtained 92–100 million
single-end 101 bp reads per sample, of which 97.6 - 98.0%
could be mapped onto the human genome. After removing
duplicated reads, which were possibly derived from PCR
artifacts, 29–31 million unique reads were mapped to the
targeted protein coding regions, resulting in an average
of 59.0 - 62.8× coverage within the targeted coding region.
Using the Genome Analysis Toolkit (GATK) we detected
19,381 - 19,656 SNPs and INDELs in the exome of each
family member, of which 98.3 - 98.4% were known variants
deposited in dbSNP 135. Given the pedigree, we searched
for autosomal-dominant, autosomal-recessive homozygous,
compound heterozygous, and de novo mutations.
Through this exome sequencing approach, we identified
two compound heterozygous mutations of the WDR62 gene
in the index patient: (i) a missense mutation (c.1313G>A)
in exon 10 that was inherited from the mother and re-
sulted in a substitution of arginine by histidine (R438H);
(ii) a frameshift mutation with deletion of 4 nucleotides
(c.2864-2867delACAG) in exon 23 that was inherited from
the father and resulted in a stop codon of the new reading
frame 112 aa downstream of the deletion (D955Afs*112).
Both mutations were confirmed by Sanger sequencing
(Figure 1C). The WDR62 gene encodes for a WD-repeat
containing protein and has been associated with autosomal
recessive primary microcephaly 2 (MCPH2, MIM*613583),
matching the phenotype of the patient. c.1313G>A has
been described previously in seven homozygous MCPH2
patients and is predicted to be deleterious [4], while c.2864-
2867delACAG is a novel mutation and could result in
nonsense-mediated decay. Indeed, WDR62 protein levels
were reduced or below detection level in EBV-transformed
lymphocytes of the index patient, when assessed via
western blot and immunocytology, respectively (Figure 2).
A survey of the types and locations of reported WDR62
mutations is schematically depicted in (Figure 1E). Inde-
pendent of the two mutations, the patient also carried a
1.66 Mb duplication at 2p12 (chr2: 82.0-83.7 Mb, hg 19).
The duplication comprising the pseudogene LOC1720
was inherited from her healthy mother and thus was
not considered as disease-causing.
Cellular phenotype of the patient with WDR62
gene mutations
We assessed the phenotypic consequences of the biallelic
WDR62 mutation in mutant lymphoblastoid cells (LCLs) of
Figure 2 Representation of WDR62 protein in immortalized lymphocytes. (A) Protein extracts were analyzed with an anti-WDR62 antibody
that recognizes amino acids 900–950. Beta-actin was used as a control for equal protein loading. Signals were visualized with
enhanced chemiluminescence. WDR62 protein levels in immortalized lymphocytes from the patient were significantly lower than in control cells (n =
3, p 0.0104, Student’s t-test). (B) Centrosomal WDR62 levels were below detection levels when assessed through immunocytology in patient cells using
the same antibody.
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normal results when compared to control specimen,
and the patient’s LCLs did not prove sensitive to ionizing
radiation or mitomycin C exposure (data not shown).
After colcemid arrest of otherwise untreated cultures,
a vast majority of mitotic cells in the patient’s LCLs
showed typical metaphase morphology (Figure 3A) in
contrast to MCPH1 cells whose characteristic feature
is an increased number of nuclei with prophase-like
chromosome (PLC) morphology (Figure 3B). Quantitative
analysis revealed a regular PLC rate of the MCPH2
LCLs, comparable to normal controls and opposed to the
increased rates in MCPH1 LCLs (Table 2).
We determined the subcellular distribution of WDR62
in LCLs of patient and controls by immunocytology.
In control cells, WDR62 localized to the centrosomes
throughout the mitotic progression with reduced signal
intensities in anaphase and telophase (Figure 4A). Cen-
trosomal WDR62 signals were relatively reduced during
interphase and then increased throughout mitosis until
anaphase, when signals dropped to interphase levels. In
anaphase telophase, WDR62 also appeared to be present
in the division plane/cytoplasm. Furthermore, WDR62
was assigned to the midbody during anaphase as shown
by co-localization with γ-tubulin (Figure 4A) for which
midbody localization has been reported [33]. In WDR62
mutant cells the co-localization of WDR62 and γ-tubulin at
the midbody appeared to be abrogated to a large extent
similar to the reduced levels at the centrosomes (Figure 4B).
In WDR62 mutant LCLs, WDR62 expression was not
detectable when assessed by immunocytology using an anti-
body against a WDR62 epitope at aa 900 to 950 (Figure 2B,
Figure 4B). Western blot using the same antibody revealed
a single band of normal size but severely reduced quantity,
suggesting that the allele with the frameshift deletion was
not expressed (otherwise a second band would be visible)
while the allele with the missense mutation had residual
expression and/or enhanced degradation and possibly a
more dispersed distribution making its immunocytological
detection impossible (Figure 2A).Since deficiency or dysfunction of WDR62 reduce
human brain size and impact on cell proliferation, we
examined the integrity of the centrosome and the mitotic
spindle apparatus in cells of the index patient and of the
controls. In control LCLs, WDR62 colocalized with the
centrosomal protein γ-tubulin throughout the cell cycle
(Figure 4A). In patient cells, WDR62 was below the detec-
tion limit. Here, we observed a more dispersed γ-tubulin
staining around the centrosome rather than a complete
loss of γ-tubulin from the centrosome (72.3% versus
9.8% of 100 counted metaphase lymphoblastoid cells of
index patient versus controls; Student’s t-test, p < 0.001)
(Figure 4B, C). Similarly, the levels of centrosomally located
CDK5RAP2 were strongly reduced in WDR62 mutant
LCLs (Figure 4D, Figure 5A,B).
We further examined the changes in mitotic spindle
organization. In controls, the spindle apparatus had a
regular bipolar form of appearance from prometaphase
to telophase (Figure 5A). Spindle defects were ob-
served in patient cells with an increase of abnormal
misdirected spindles with broad and unfocused poles
of microtubules (Figure 5B). Quantification of the
metaphase cell population indicated that more than
half of WDR62-depleted cells exhibited such abnormal
bipolar spindles (87.6% versus 10.2% of 115 counted
metaphase LCLs of index patient versus controls; Stu-
dent’s t-test, p < 0.0001) (Figure 5C). Mutant cells also
showed displaced centrosomes detected by co-staining
with both CDK5RAP2 and alpha-tubulin (Figure 4D).
In addition, the spindle pole distance was significantly
increased in mutant cells compared to controls
(2.46 μm versus 2.1 μm of 115 counted metaphase lym-
phoblastoid cells of index patient versus controls; Stu-
dent’s t-test, p < 0.0001) (Figure 5C). Given the
importance of assembly of bipolar mitotic spindles for
accurate chromosome segregation, we investigated the
alignment of chromosomes in patient cells. We noted
the presence of lagging chromosomes in some lympho-
blastoid cells from the patient compared to the con-
trols (Figure 6).
Table 2 Rate of nuclei with prophase-like chromosome
(PLC) morphology
Designation Mean [%] PLC Rate SD [%] Range [%] n
MCPH2 Patient 1.36 ± 0.5 0.79-2.33 7
Normal Controls 1.17 ± 0.85 0-2.09 8
MCPH1 Patients 9.07 ± 4.02 5.96-13.77 3
N: number of independent experiments in the reported MCPH2 patient or
number of individuals with single experiments in normal and MCPH1 controls.
Figure 3 Absence of a prophase-like chromosome phenotype
in MCPH2 deficiency. (A) Normal metaphase morphology (arrow)
of a cultured lymphoblast in a cell line from the MCPH2 patient after
induced mitosic arrest by colcemid. The chromosomes are
condensed while the delimitation of the metaphase is irregularly
shaped suggesting that there is no more nuclear membrane after its
disintegration in prophase. Three other nuclei are stained rather
homogeneously, typical of uncondensed chromatin in interphase
nuclei (asterisks). (B) An MCPH1 lymphoblastoid cell line treated
identically shows nuclei with typical prophase-like chromosome (PLC)
morphology. Virtually all of the six nuclei reveal a meandering striped
or banded chromatin structure characteristic of beginning chromo-
some condensation (best seen in the two marked nuclei). Despite
prometaphase stage, they present with rounded delimitations (ar-
rows) suggesting that they are bounded by a persisting nuclear
membrane, a phenomenon that is designated as premature
chromosome condensation (PCC). Giemsa stain.
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Phenotype and genotype
We report compound heterozygous WDR62 mutations
in a German girl with primary microcephaly: (i) a missense
mutation with single nucleotide transition c.1313G>A in
exon 10 resulting in the substitution of arginine by histidine
(R438H) which has been reported previously in homozygous
patients (4), and (ii) a novel frameshift deletion of four nu-
cleotides c.2864-2867delACAG in exon 23 that resulted in a
stop codon of the new reading frame 112 aa downstream of
the deletion (p.D955Afs*112) (Figure 1). The index patient
had congenital microcephaly, intellectual disability, speech
deficit, and epilepsy. Apart from typical facial features of
MCPH including a sloping forehead, she had only minor
dysmorphic features (convex profile with small chin), and
her height and weight were normal. There was no further
neurological deficit and her sensorial functions were normal.
The postnatal cranial ultrasound of the patient revealed
small frontal lobes, simplified hippocampal gyration, and
hypoplasia of both the corpus callosum and the cerebellum.
Despite the classical definition of MCPH as a severe
congenital microcephaly lacking morphological ab-
normalities of the brain, it is now acknowledged that
particularly MCPH patients with WDR62 mutations
may have a wide spectrum of brain malformations in
addition to microcephaly including pachygyria, thickened
cortex, polymicrogyria, schizencephaly, corpus callosum,
and hippocampal abnormalities as well as cerebellar
hypoplasia [4,7,12], in line with the phenotype of the
index patient (Table 1).
Although cancer has not been described so far in
patients with MCPH2, individual patients with other
MCPH subtypes and leukemia have been reported [2,34].
Moreover, mouse models of MCPH3 and MCPH5 dis-
played an increased tumor risk and/or blood abnormalities
(anemia, leucopenia) [35,36]. It is likely that the deceased
sister of the index patient who also had severe micro-
cephaly at birth and intellectual disability, carried the
p.R438H / p.D955Afs*112 mutations of the WDR62 gene.
(Unfortunately, her DNA was not available for genetic
testing anymore.) The diagnosis of a Wilms tumor in
association with a putative WDR62 mutation raises
concerns regarding a potentially increased cancer risk
in MCPH2 patients also. In addition, especially in pa-
tients with MCPH1 and MCPH5, early puberty, renal
agenesis, and multicystic kidneys have been described.
As this point warrants further investigation in patients,
we investigated the clinical phenotype of our patient in
detail but found no evidence of blood abnormalities,
organ involvement, or malignancy.
Effect of WDR62 mutations
Most previously reported WDR62 mutations have
been proposed to lead to loss of WDR62 function
Figure 4 WDR62 in immortalized lymphocytes and dispersion of centrosomal proteins γ-tubulin and CDK5RAP2 in WDR62 mutant
patients cells. Subcellular localization of WDR62 (red) and γ-tubulin (green) throughout the cell cycle in immortalized lymphocytes of (A) controls
and (B) the MCPH2 patient. In controls, WDR62 colocalized with γ-tubulin and was present on the centrosome with high levels throughout
mitosis until anaphase and telophase, thereafter the signal intensity dropped to interphase levels. Gamma-tubulin immunostaining shows distinct
centrosomes in controls whereas in patient cells the γ-tubulin-marked centrosomes appear broad and dispersed. (C) Quantification results of
abnormal centrosomes with a dispersed γ-tubulin staining around the centrosome (n = 100 metaphase lymphoblastoid cells, p = 0.0006, Student’s
t-test). (D) Abnormal localization of centrosomal protein CDK5RAP2 (red) in WDR62 mutant patient immortalized lymphocytes (see also Figure 5).
Cells were stained for WDR62, for the centrosome marker CDK5RAP2, and for α-tubulin as a microtubuli marker. DNA was stained with
DAPI (blue).
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(p.D955Afs*112) in the present patient leads to a stop
codon in the novel reading frame. Since the Western
blot revealed only a single band of normal size we as-
sume that this allele’s RNA is subject to nonsense-mediated decay and that its protein product is not
expressed (Figure 2A). The previously reported missense
mutation present also in our index patient (p.R438H)
alters evolutionarily highly conserved amino acids of
WDR62 [4].
Figure 5 Spindle defects in WDR62 mutant patient cells. Subcellular localization of CDK5RAP2 and α-tubulin throughout the cell cycle in
immortalized lymphocytes of (A) control and (B) MCPH2 patient. While the spindle apparatus has a regular bipolar form of appearance from
prometaphase to telophase in controls, patient cells show abnormal spindle formation with an increase of abnormal misdirected spindles and
broad, unfocused microtubules poles. CDK5RAP2 signals are weaker in patient’s cells than in controls. Cells were stained for CDK5RAP2 (red), for
α-tubulin (green), and for DNA using DAPI (blue). (C) Quantification results of abnormal spindles and spindle pole distance (n = 115 metaphase
lymphoblastoid cells, p < 0.0001, Student’s t-test).
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results from in vivo and in vitro studies, to result from a
premature shift from symmetric to asymmetric neural
progenitor-cell divisions (with a subsequent depletion
of the progenitor pool) and from a reduction in cell survival
[37,38]. A central molecular mechanism for microcephaly
in MCPH2 may be a deficiency or dysfunction of WDR62
at the spindle pole of dividing cells due to processessuch as non-expression, loss of essential spindle target-
ing domains, misfolding or rapid degradation of the
mutant protein [39]. For WDR62 it has been recently
demonstrated that siRNA downregulation in murine neural
progenitors through in utero electroporation induces
early cell cycle exit and a reduced proliferative capacity.
Downregulation by siRNA of WDR62 in murine neural
progenitors causes early cell cycle exit and reduced
Figure 6 Lagging chromosomes in mutant WDR62 lymphocytes.
Some chromosomes in patient cells showed lagging defects in
metaphase (indicated by arrows).
Farag et al. Orphanet Journal of Rare Diseases 2013, 8:178 Page 12 of 14
http://www.ojrd.com/content/8/1/178proliferative capacity [13]. Moreover, WDR62 downreg-
ulation in tumor cells (HeLa) was associated with spin-
dle orientation defects, decreased centrosome integrity
and displacement from the spindle pole as well as de-
layed mitotic progression [13].
Cellular phenotype
To study the effect of the reported compound heterozygous
WDR62 gene mutations on centrosome and spindle
integrity in the present index patient, we analyzed the
intracellular localization of WDR62 as well as centrosome
and spindle morphology of EBV-transformed lymphocytes
(LCLs) from the patient and from controls. WDR62
localized to the centrosomes of control LCLs at all phases
of the cell cycle in a cycle-dependent manner, with low
centrosomal WDR62 levels in anaphase and telophase.
In interphase, WDR62 was also only weakly associated with
the γ-tubulin-labeled centrosome; moreover, WDR62 ex-
pression appeared to be cytosolic (Figure 4). These findings
are in line with previous reports of WDR62 localization in
human tumor cells (HeLa, HEK293, A549, HepG2), human
non-tumor cells including B-lymphocytes as well as mouse
cerebral cortex neuroepithelial cells at E13. Here WDR62
was reported to assume both nuclear and cytosolic dis-
tribution in interphase by some authors [4,6,12,13],
while accumulating strongly at the spindle poles during
mitosis [4,6,12,13] with no obvious centrosomal associ-
ation of WDR62 during anaphase and telophase [13].
We also detected WDR62 protein accumulation in the
division plane (midbody) in lymphoblastoid cell lines, a re-
gion of bipolar microtubuli array that arranges between sep-
arating sister chromatids during anaphase [40]. Contrary to
our results, no protein accumulation was detected at the
midbody during cytokinesis in previous localization reports
performed in other cell lines (HeLa, HEK293, A549, HepG2)
[4,6,12]. Further studies are needed to address the asso-
ciation of WDR62 with the midbody. In one report, the
mitotic WDR62 distribution was evaluated by itscolocalization with CDK5RAP2, a key centrosomal pro-
tein known to cause MCPH3 when disrupted. WDR62
and CDK5RAP2 colocalized to the centrosome through-
out the cell cycle. However, during prometaphase and
metaphase, WDR62 surrounded rather than strictly coloca-
lized with CDK5RAP2 at the centrosome [7].
WDR62 protein levels were low (western blot) or non-
detectable (immunocytology) in MCPH2 patient cells. As
indicated above, this finding may result from nonsense-
mediated decay of the transcript with the frameshift
deletion and dispersion and/or instability of the protein
with the missense mutation (Figures 2 and 4). In contrast
to siRNA studies on WDR62 downregulation, we detected
neither a disorder of cell cycle progression in peripheral
lymphocytes of the patient nor increased chromosomal
breakage rates of her LCLs when compared to controls.
We could, however, detect a failure of the centrosomal
proteins γ-tubulin and CDK5RAP2 to localize properly
at the centrosome in patient cells indicating an abnormal
centrosome integrity (Figures 4 and 5). In addition, spindles
were disorganized in patient cells with displaced cen-
trosomes, increased spindle pole distance, and lagging
chromosomes (Figures 5 and 6). These results are in line
with those of Bogoyevitch et al. 2012 [13] who observed
abnormal metaphase spindles characterized by a dis-
placement of centrosomes from the spindle pole and a
significant increase of spindle length. Thus, the recent
appreciation of a relationship between proper centrosome
attachment to the spindle pole and spindle length deter-
mination [41,42] is reinforced. Since spindle function is im-
portant for correct chromosome alignment at the spindle
equator and this again is necessary for accurate segregation
of chromosomes during cell division into two daughter cells
[43], we investigated these processes. Our observation
of disturbed metaphase chromosome alignment and of
lagging chromosomes in some lymphoblastoid cells from
the patient is in line with previous reports demonstrating
an increase in the proportion of unaligned chromosomal
DNA during metaphase in HeLa cells following WDR62
siRNA [13]. This is consistent with delayed mitotic progres-
sion and disrupted centrosome/bipolar spindle organization
[13], emphasizing the importance of regulated assembly of
the mitotic spindle apparatus that impact the forces acting
on chromosomes.
Conclusion
Tight and timely control of cell division largely determines
brain size during embryonic development [44]. Our results,
although generated in human patient lymphocytes and
not human neural progenitors, suggest that spindle
defects and a disruption of centrosome integrity could
play a role in the development of microcephaly in MCPH2.
In fact, our results on lymphoblastoid cells from a MCPH2
patient are in line with those detected in two MCPH5
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derived from iPS cells of MCPH patients may provide
further confirmation.
Additional file
Additional file 1: Figure S1. Picture of sibling. Picture of the patient’s
sister (II:1, see pedigree in Figure 1A) at the age of 1.5 years. She also had
microcephaly and intellectual disability, and she died of a Wilms tumor at
the age of 5 years.
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